Jorveza

Budesonide, the active ingredient in Jorveza, is a corticosteroid presented as an oral formulation for oral use. It is indicated for the treatment of inflammatory bowel conditions such as Crohn's disease and ulcerative colitis, helping to reduce intestinal inflammation in adult patients.

GNH USA supplies Jorveza as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Jorveza is a corticosteroid that targets inflammatory processes in the gastrointestinal tract. - Crohn's disease: reduces intestinal inflammation and helps maintain remission. - Ulcerative colitis: alleviates mucosal inflammation and promotes symptom relief. - Inflammatory bowel disease (IBD): provides anti‑inflammatory control across the disease spectrum.

Adverse reactions may occur with oral budesonide therapy.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Abdominal pain: cramping or discomfort in the stomach area. - Oral thrush: fungal overgrowth in the mouth.

Serious or Rare Side Effects: - Adrenal suppression: reduced endogenous cortisol production. - Severe infection: increased susceptibility to bacterial, viral or fungal infections. - Hypersensitivity reactions: rash, itching or anaphylaxis in rare cases.

Before initiating therapy, clinicians should consider several safety measures. - Assess adrenal function: evaluate baseline cortisol levels when long‑term use is planned. - Monitor for infections: watch for signs of bacterial, viral or fungal infections. - Use lowest effective dose: limit exposure while achieving clinical benefit. - Avoid abrupt discontinuation: taper gradually to prevent withdrawal. - Store at room temperature: keep in the original pack, protect from moisture.

Budesonide may interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic budesonide exposure. - Systemic immunosuppressants (e.g., azathioprine): combined use can heighten infection risk.

Moderate Interactions (Monitor Closely): - Antacids: may reduce budesonide absorption. - Live vaccines: efficacy may be diminished. - Diuretics: may increase risk of hypokalemia when used together.